Abstract

Glioblastoma remains one of the deadliest brain malignancies. First-line therapy consists of maximal surgical tumor resection, accompanied by chemotherapy and radiotherapy. Malignant cells escape surgical resection by migrating into the surrounding healthy brain tissue, where they give rise to the recurrent tumor. Based on gene expression, tumor cores can be subtyped into mesenchymal, proneural, and classical tumors, each being associated with differences in genetic alterations and cellular composition. In contrast, the adjacent brain parenchyma where infiltrating malignant cells escape surgical resection is less characterized in patients. Using spatial transcriptomics (n = 11), we show that malignant cells within proneural or mesenchymal tumor cores display spatially organized differences in gene expression, although such differences decrease within the infiltrated brain tissue. Malignant cells residing in infiltrated brain tissue have increased expression of genes related to neurodevelopmental pathways and glial cell differentiation. Our findings provide an updated view of the spatial landscape of glioblastomas and further our understanding of the malignant cells that infiltrate the healthy brain, providing new avenues for the targeted therapy of these cells after surgical resection.

In glioblastoma, malignant cells can escape surgical resection by migrating into the surrounding healthy brain tissue. Here, the authors use spatial transcriptomics to characterise the tumour core and infiltrated brain regions in glioblastoma, and show shifts in malignant cell composition and molecular pathways with potential clinical implications.

Details

Title
Glioblastoma cells increase expression of notch signaling and synaptic genes within infiltrated brain tissue
Author
Harwood, Dylan Scott Lykke 1   VIAFID ORCID Logo  ; Pedersen, Vilde 2   VIAFID ORCID Logo  ; Bager, Nicolai Schou 1 ; Schmidt, Ane Yde 3 ; Stannius, Tobias Overlund 3 ; Areškevičiūtė, Aušrinė 4   VIAFID ORCID Logo  ; Josefsen, Knud 5 ; Nørøxe, Dorte Schou 6   VIAFID ORCID Logo  ; Scheie, David 7 ; Rostalski, Hannah 1 ; Lü, Maya Jeje Schuang 8 ; Locallo, Alessio 9 ; Lassen, Ulrik 6   VIAFID ORCID Logo  ; Bagger, Frederik Otzen 3   VIAFID ORCID Logo  ; Weischenfeldt, Joachim 10 ; Heiland, Dieter Henrik 11   VIAFID ORCID Logo  ; Vitting-Seerup, Kristoffer 12 ; Michaelsen, Signe Regner 2   VIAFID ORCID Logo  ; Kristensen, Bjarne Winther 2   VIAFID ORCID Logo 

 University of Copenhagen, Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Copenhagen University Hospital, The Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373) 
 University of Copenhagen, Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Copenhagen University Hospital, The Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Copenhagen University Hospital, DCCC Brain Tumor Center, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373) 
 Copenhagen University Hospital, Genomic Medicine, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373) 
 Copenhagen University Hospital, Danish Reference Center for Prion Diseases, Department of Pathology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373) 
 Copenhagen University Hospital, The Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373) 
 Copenhagen University Hospital, DCCC Brain Tumor Center, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Copenhagen University Hospital, Department of Oncology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373) 
 Copenhagen University Hospital, Department of Pathology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373) 
 University of Copenhagen, Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Copenhagen University Hospital, DCCC Brain Tumor Center, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Copenhagen University Hospital, Department of Oncology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Rigshospitalet, The Finsen Laboratory, Copenhagen, Denmark (GRID:grid.475435.4) 
 University of Copenhagen, Department of Clinical Medicine and Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Copenhagen University Hospital, DCCC Brain Tumor Center, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Rigshospitalet, The Finsen Laboratory, Copenhagen, Denmark (GRID:grid.475435.4) 
10  Copenhagen University Hospital, DCCC Brain Tumor Center, Rigshospitalet, Copenhagen, Denmark (GRID:grid.4973.9) (ISNI:0000 0004 0646 7373); Rigshospitalet, The Finsen Laboratory, Copenhagen, Denmark (GRID:grid.475435.4) 
11  Medical Center—University of Freiburg, Department of Neurosurgery, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203); Medical Center—University of Freiburg, Microenvironment and Immunology Research Laboratory, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203); Northwestern University Feinberg School of Medicine, Department of Neurological Surgery, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507); partner site Freiburg, German Cancer Consortium (DKTK), Freiburg, Germany (GRID:grid.16753.36) (ISNI:0000 0004 7865 6683) 
12  Technical University of Denmark (DTU), Section for Bioinformatics, Health Technology, Kongens Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870) 
Pages
7857
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3102223656
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.